Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ALTI-MEXILETINE 100 MG

MEXILETINE HYDROCHLORIDE : 100 MG · DIN 02231690 · ALTIMED PHARMA INC.

Health Canada status: CANCELLED POST MARKET

What is ALTI-MEXILETINE?

ALTI-MEXILETINE 100 MG contains MEXILETINE HYDROCHLORIDE : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02231690, held by ALTIMED PHARMA INC., supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 05-Sep-2001. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02231690
Brand nameALTI-MEXILETINE
Generic / active ingredientMEXILETINE HYDROCHLORIDE : 100 MG
ManufacturerALTIMED PHARMA INC.
Strength100 MG
Dosage formCAPSULE
Route of administrationORAL
SchedulePrescription
ATC codeC01BB02 MEXILETINE
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date05-Sep-2001

How is this product identified?

Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.

DIN (8-digit, as used in Nexara ordering)02231690
DIN (unpadded, as printed on some documents)2231690
Brand nameALTI-MEXILETINE
Active ingredient / INNMEXILETINE HYDROCHLORIDE : 100 MG
ATC codeC01BB02
ATC anatomical main groupC — Cardiovascular system
ATC therapeutic subgroupC01
Health Canada schedulePrescription
Biosimilar biologicNo
Market authorization holderALTIMED PHARMA INC.

Which pack is which?

Strength on the label100 MG
Dosage formCAPSULE
RouteORAL

One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Confirm the pack and get a price

What can be used instead?

Other Canadian products sharing ATC code C01BB02 MEXILETINE. 4 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
MINT-MEXILETINE100 MGCAPSULEMINT PHARMACEUTICALS INCMARKETEDDIN 02536846
MINT-MEXILETINE200 MGCAPSULEMINT PHARMACEUTICALS INCMARKETEDDIN 02536854
TEVA-MEXILETINE100 MGCAPSULETEVA CANADA LIMITEDMARKETEDDIN 02230359
TEVA-MEXILETINE200 MGCAPSULETEVA CANADA LIMITEDMARKETEDDIN 02230360
ALTI-MEXILETINE200 MGCAPSULEALTIMED PHARMA INC.CANCELLED POST MARKETDIN 02231692
MEXITIL CAP 100MG100 MGCAPSULEBOEHRINGER INGELHEIM (CANADA) LTD LTEECANCELLED POST MARKETDIN 00599956
MEXITIL CAP 200MG200 MGCAPSULEBOEHRINGER INGELHEIM (CANADA) LTD LTEECANCELLED POST MARKETDIN 00599964

Can this still be bought in Canada?

No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.

If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 02231690. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.